ÌÇÐÄÆƽâ°æ

FDA emergency use authorizations for Covid-19 tests as of 20 March, 2020, by company 1-day share price move*

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

March 2020

Region

United States

Survey time period

as of March 20, 2020

Supplementary notes

* Excludes academic-developed tests.

Citation formats

Covid-19 tests emergency authorized by FDA 20th March 2020, by price move

Published by
Conor Stewart,
Mar 26, 2020
As of March 20, 2020, nine companies have had Covid-19 diagnostic tests authorized by the U.S. FDA. This statistic shows the FDA emergency use authorisations for Covid-19 tests (excluding academic-developed tests) as of 20 March, 2020, by 1-day share price move. After GenMark Diagnostics got an emergency use authorization (EUA) on March 19, its share price increased 41 percent over one day.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

Coronavirus disease (COVID-19) pandemicCoronavirus COVID-19 in ChinaCoronavirus (COVID-19) in ItalyCoronavirus (COVID-19) in the U.S.Coronavirus (COVID-19) in Latin America
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.